(1) To be approved by the Board as an independent clinical evaluator, an evaluator must be:
- (a) Licensed as required by the jurisdiction in which the evaluator works;
- (b) Able to provide a comprehensive assessment of and written report describing a licensee’s diagnosis, degree of impairment, and treatment recommendations; and
- (c) Able to facilitate toxicology testing of the licensee at intake.
- (2) The Board reserves the right to not approve an independent clinical evaluator for any reason.
- (3) The Board or contractor will not accept an evaluator as independent in a particular case if, in the Board’s or contractor’s judgment, the evaluator’s judgment is likely to be influenced by a personal or professional relationship with a licensee.
Statutory/Other Authority
ORS 676.190, 677.265 & 676.200
Statutes/Other Implemented
ORS 676.190, 676.185, 676.200, 676.194 & OL 2025, chapter 499, sections 2-3
History
OMB 4-2026, amend filed 01/12/2026, effective 01/12/2026
OMB 19-2022, amend filed 10/12/2022, effective 10/12/2022
OMB 33-2012, f. & cert. ef. 10-22-12
OMB 17-2012(Temp), f. & cert. ef. 7-31-12 thru 1-15-13
OMB 9-2011, f. & cert. ef. 4-25-11
BME 20-2010, f. & cert. ef. 10-25-10
BME 15-2010(Temp), f. & cert. ef. 8-3-10 thru 1-18-11